Considering the oncogenic nature of AP-2γ, the loss of WWOX and overexpression of YAP in high BLCA grade, this might represent a partnership switch from WWOX–AP-2γ to YAP–AP-2γ. The gene discussed is WWOX; the disease is bladder transitional cell carcinoma.